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Abstract 
Despite growing interest in the temporal dynamics of Major Depressive Disorder (MDD), we 
know little about the intra-day fluctuations of key symptom constructs. In a study of 
momentary experience, the Experience Sampling Method captured the within-day dynamics 
of negative affect, positive affect, self-esteem, passive suicidality, and tiredness across 
clinical MDD (N=31) and healthy control groups (N=33). Ten symptom measures were taken 
  
per day over 6 days (N=2,231 observations). Daily dynamics were modeled via intra-day 
time-trends, variability, and instability in symptoms. MDD participants showed significantly 
increased variability and instability in negative affect, positive affect, self-esteem, and 
suicidality. Significantly different time-trends were found in positive affect (increased diurnal 
variation and an inverted U-shaped pattern in MDD, compared to a positive linear trend in 
controls) and tiredness (decreased diurnal variation in MDD). In the MDD group only, 
passive suicidality displayed a negative linear trend and self-esteem displayed a quadratic 
inverted U trend. MDD and control participants thus showed distinct dynamic profiles in all 
symptoms measured. As well as the overall severity of symptoms, intra-day dynamics appear 
to define the experience of MDD symptoms. 
  
Keywords: Experience Sampling Method (ESM) / Ecological Momentary Assessment (EMA); 
depression; daily symptom dynamics; circadian rhythms; emotional instability / variability 
 
1. Introduction 
Recent research has found that dynamics in affect are an integral part of depression 
(Houben, et al., 2015; Pe et al., 2015). This has led to calls for affective dynamics to be 
included in the diagnostic criteria for major depressive disorder (MDD; Bowen at al., 2013). 
It would follow that other MDD symptoms are dynamic in nature, and that these dynamics 
are as important as overall symptom levels or intensity. However, very little research exists 
on the within-day dynamics of MDD symptoms other than affect. This study aims to obtain a 
descriptive picture of the daily fluctuations and rhythms of a range of symptom constructs in 
MDD.  
  
By its very nature, MDD is a dynamic constuct: symptoms are known to change over 
time, with MDD episodes fluctuating across remission, pro-dromal, and more clinically 
severe periods at different points over months and years (Fried et al., 2016; Iacoviellow et al., 
2010; Vergunst et al., 2013). Theory also suggests that depressive symptoms fluctuate at a 
more micro-level: for example, cognitive-behavioral as well as more recent work suggests 
that depressive symptoms are activated on a moment-to-moment basis over the course of 
daily life (Beck et al., 1979; Wichers, 2014). Alterations in the circadian rhythms of 
biological processes such as cortisol and melatonin secretion have also been found to be 
associated with depression (Peeters et al., 2003; Sundberg et al., 2016). Research and theory 
on the factors underlying MDD therefore outline inherently dynamic processes that occur 
within the context of an individual’s everyday life. However, to date, research on MDD 
symptoms has relied mostly on measures and diagnostic conceptualizations of MDD that do 
not capture the daily flow of MDD experience.  
We use the Experience Sampling Method (ESM; Csikszentmihalyi and Larson, 1987; 
Stone and Shiffman, 1994) to empirically assess the intra-day dynamics of five key MDD 
symptom dimensions (adapted to the momentary micro-level from macro-level DSM / ICD 
diagnostic criteria) in a sample of MDD and healthy control participants. At the macro-level, 
MDD is not a unidimensional construct; rather, it is a syndrome comprised of heterogeneous 
symptoms that are distinct etiologically and have differential effects on biopsychosocial 
functioning (Fried et al., 2016; Fried and Nesse, 2014). Indeed, an in-depth symptom-level 
approach to MDD research has recently been proposed (Fried and Nesse, 2015). Macro-level 
symptoms are expressions of micro-level, moment-to-moment symptom experience 
(Wichers, 2014). In the present study, we therefore study micro-level symptoms separately, 
rather than as part of one construct. Alongside positive affect (PA) and negative affect (NA), 
the dynamics of self-esteem, tiredness, and suicidality are explored. The symptoms include 
  
cognitive and affective symptoms, as well as a somatic, non-affective symptom (tiredness). 
These symptoms were chosen as the focus of study over others (e.g. appetite changes, 
psychomotor symptoms and concentration difficulties) because they have been the focus of 
previous ESM research. As such, they have all been found to have within-day fluctuations 
and are known to be subjective experiences that can be studied effectively with ESM.  
1.1. Conceptualizing ‘dynamics’ and their operationalization in affect  
This study conceptualizes the temporality of symptoms in three ways, as: (1) 
variability in symptom scores across the sampling period; (2) instability in symptom scores 
between moments; and (3) systematic trends in hour-by-hour symptom levels. Below, each 
conceptualization is defined and a brief summary is given of how such measures have been 
operationalized in relation to affect in MDD. 
1.1.1. Defining variability and instability. These concepts are defined comprehensively 
elsewhere (see Houben et al, 2015 and Jahng et al., 2008). In short, symptom variability 
captures the overall spread of an individual’s symptom scores across a sampling period (i.e. 
intra-individual variance or standard deviation). Instability is a more temporally contingent 
measure, capturing the frequency and amplitude of symptom fluctuations between moments. 
It is the within-person successive difference in between-moment symptom scores. 
1.1.2. Affect variability and instability. The extent to which affect fluctuates during the day is 
a central part of subjective emotional experience. In the past decade, a body of research has 
found that greater variability and instability in NA are related to poor psychological well-
being in general and MDD in particular (Houben et al., 2015; Wichers et al., 2010).  
The relationship between PA instability/variability and MDD is less clear. In their 
meta-analysis, Houben et al. (2015) found that although PA variability/instability was 
  
positively associated with poorer psychological health, it was a less powerful predictor of this 
than NA variability/instability. Studies on clinical populations have typically found no 
significant association between PA variability/instability and MDD (Peeters et al., 2006; 
Thompson et al., 2012). Indeed, when the Houben et al. meta-analysis was confined to 
studies with clinical populations, MDD was actually associated with less variability (though 
not instability) in PA.  
Given that depression is thought to be a dimensional construct (Prisciandaro and 
Roberts, 2005), it is not clear why studies have found that increased PA instability and 
variability are associated with depressive symptoms in the general population, but not with 
depression diagnosis in clinical populations (Gruber et al., 2013; Houben et al., 2015). 
Indeed, Houben et al. describe their finding that less variability is associated with clinical 
depression as ‘anomalous’, while also suggesting that less PA variability may reflect the 
MDD experience of anhedonia and resulting lack of PA reactivity. The research in that review 
includes studies using different methodologies (e.g. both ESM and retrospective measures), 
different time-scales between reports (between-day reports and intra-day reports) and 
different calculations of variability/instability (e.g. multilevel vs. single level 
variability/instability analyses). Given these marked methodological and measurement 
differences, a coherent body of research on intra-day, hour-to-hour PA variability/instability 
in MDD has not yet formed. Indeed, the number of studies that have explored intra-day 
variability/instability in affect in MDD remains relatively small. As a result, the relative 
importance and roles of PA and NA variability and instability in MDD is unclear. Further 
research on clinical samples using fine-grained, multilevel ESM methods is needed to 
establish these.  
1.1.3. Defining diurnal time-trends. Neither variability nor instability directly account for 
how time itself may influence symptom levels. In contrast, the time-trend approach models 
  
symptom severity as a function of time of day. It identifies any systematic patterns of change 
in symptom levels across the day. Just as research on biological circadian rhythms has shown 
that certain circadian patterns are associated with disease outcomes (Takahashi et al., 2008), 
so too may diurnal rhythms in psychological experience play a key role in functioning and 
outcomes in depression. 
1.1.4. Diurnal time-trends in affect. Relatively little research exists on diurnal affective 
rhythms in MDD (indeed, diurnal time-trends were not included in Houben et al.’s 2015 
meta-analysis of affect dynamics). Traditional clinical descriptions of MDD incorporate a 
‘morning-worse’ pattern in affect (Hall et al., 1964; Leibenluft et al., 1992). However, the few 
studies that have systematically investigated diurnal time-trends in affect have yielded 
conflicting results.  
One ESM study found a ‘morning-worse’ pattern in both NA and PA (Peeters et al., 
2006). MDD participants exhibited an inverted U-shaped pattern in NA with a peak in the 
mid-morning, while the NA of control participants did not exhibit a diurnal trend. PA 
displayed an inverted U-shaped pattern in both groups. MDD participants, however, showed a 
significantly steeper slope in PA over the day, with relatively lower morning and higher 
evening levels. These findings are similar to those of Daly et al. (2011), where individuals 
with high levels of psychological distress had a more pronounced diurnal affective rhythm 
than those with low distress levels, characterized by much lower morning PA and somewhat 
higher morning NA. In contrast, Murray (2007) found a less distinct diurnal quadratic rhythm 
in PA in individuals with high depression levels compared to those with low depression 
levels. NA was not found to have a time-trend in either group. Mata et al. (2012) found no 
differences between MDD and control groups in the time-trend of either NA or PA.  
  
Peeters et al. (2006) is the only study we are aware of that used a clinical MDD 
sample in its investigation of time-trends. Mata et al. (2012) used a community sample that 
was diagnosed with/without MDD using structured clinical interviews, while both Murray 
(2007) and Daly et al. (2011) used non-clinical samples (indeed, while the PA time-trend 
differed across high and low depression scorers in Murray (2007), mean levels in PA were not 
significantly different between groups). The nuances of differences in diurnal patterns of 
affect may only be apparent in individuals with clinically more severe MDD. Further research 
on clinical samples is therefore needed to establish a consensus on the daily affective time-
trend of MDD. 
1.2. The Intra-Day Dynamics of Self-Esteem, Suicidality, and Tiredness in MDD 
 Taken together, research on the intra-day dynamics of affect strongly suggests that 
dynamic change is a core characteristic of MDD. It emphasizes the need to move beyond 
static conceptualizations of affect, where an individual’s average levels are the only aspect 
considered. The dynamics revealed by these studies point to increased emotional fluctuations 
in MDD and difficulties in regulating daily subjective experience. It follows that other key 
MDD symptoms – such as self-esteem, suicidality and tiredness – may also be characterized 
by specific dynamic patterns. However, as discussed below, research has continued to focus 
on absolute levels of these symptoms in MDD and has not yet considered in detail the nature 
and pattern of their intra-day fluctuations. 
1.2.1. Self-Esteem. Low self-esteem is related to both the aetiology and symptomatology of 
MDD. The DSM-5 specifies daily feelings of ‘worthlessness’ as part of its MDD diagnostic 
criteria, the ICD-10 specifically refers to ‘reduced self-esteem and self-confidence’ (World 
Health Organization, 2010), and most psychological models propose that MDD is maintained 
via pervasive negative views of the self (e.g. Beck et al., 1979). The current study uses the 
  
concept of ‘self-esteem’ rather than the specific symptom of ‘worthlessness’ to allow a 
comparison with previous research on self-esteem variability. Items measuring self-esteem 
tend to be more moderately phrased than those that measure worthlessness, and thus are more 
likely to detect intra-day variation (Palmier-Claus et al., 2011). 
 Prospective studies have consistently found that low self-esteem predicts depression 
in clinical and non-clinical samples (Orth et al., 2008; Rieger et al., 2016; Sowislo and Orth, 
2013). A proposed mechanism behind the relationship between low self-esteem and MDD is 
self-esteem variability, where relative drops in daily self-esteem trigger and maintain MDD 
(Kernis et al., 1998). Cross-sectional work has found higher levels of day-to-day variability in 
self-esteem in individuals currently experiencing depression (Franck and De Raedt, 2007; 
Sowislo et al., 2014), while prospective studies have found that such day-to-day self-esteem 
variability predicts future depression (Study 2 – Butler et al., 1994; Franck and De Raedt, 
2007; Kernis et al., 1998). However, the strength of the relationship between depression and 
self-esteem variability is unclear, as the associations found in some of these cross-sectional 
and prospective studies have been weak or non-significant (Study 1 - Butler et al., 1994; 
Sowislo et al., 2014).  
Previous work on self-esteem variability in MDD has two major limitations. Firstly, a 
maximum of two self-esteem measures per day have been used to derive self-esteem 
variability (Sowislo et al., 2014; Kernis et al., 1998). ESM studies on other populations have 
demonstrated that self-esteem variability can occur over a much shorter time frame, from 
hour-to-hour (Knowles et al., 2007; Thewissen et al., 2011). No high-frequency ESM study of 
self-esteem has yet been conducted on an MDD sample. This is a possible reason for the 
weak or non-significant associations found in some studies: as self-esteem likely fluctuates at 
a faster rate than day-to-day, studies with low sampling rates (i.e. one or two measurements 
per day) may not reliably pick up variability in this symptom. 
  
A second limitation is that previous research has focused on a single dimension of 
self-esteem dynamics: intra-individual variability (standard deviation) across day-to-day 
measures. To our knowledge, no research has yet directly investigated the extent of between-
moment instability in self-esteem in MDD; rather, previous work has used day-to-day 
variability as a proxy for self-esteem instability. Furthermore, research has not yet explored 
diurnal time-trends in self-esteem in healthy or MDD populations. The current study thus 
aims to improve upon previous literature by (1) using a high-frequency ESM protocol and (2) 
studying multiple aspects of self-esteem fluctuations to provide a more nuanced account of 
self-esteem dynamics in MDD.  
1.2.2. Suicidality.  Understanding the dynamics of suicidal ideation is of public health 
importance. Lability in suicidality may indicate difficulties in regulating intrusive suicidal 
thoughts (indicating suicide risk), while determining suicidality’s diurnal time-course would 
highlight micro-periods of increased risk for suicide. A small number of previous studies 
indicate that micro-level variation is a feature of suicidality. Day-to-day instability in suicidal 
ideation has been found to have a stronger association with previous suicide attempts than 
duration or intensity of ideation (Witte et al., 2005; Witte et al., 2006). Furthermore, suicidal 
behavior has been found to follow a diurnal course: research on Italian suicide statistics, 
where time of death is routinely reported, has found that most suicides take place in the 
morning-time (Preti and Miotto, 2001; Williams and Tansella, 1987).  
Little evidence exists on the intra-day dynamics of subjective suicidality. Two studies 
have investigated the diurnal time-trend of subjective suicidality (Nock et al., 2009; Husky et 
al., 2014). Contrary to work on suicidal acts, neither found suicidality to have a significant 
time-trend. To our knowledge, no study has yet used ESM to explore intra-day variability or 
instability in suicidality.  
  
Previous studies have been limited in their ability to detect within-day variation in 
suicidality due to low sampling frequencies (two signals emitted per day in Nock et al., 2009 
and five in Husky et al., 2014). They also investigated only one aspect of suicidality: active 
suicidal thoughts. These thoughts were found to be relatively rare (7.8% of reports in Husky 
et al., 2014 and an intra-individual average of 1.1 suicidal reports per week in Nock et al, 
2009). Other dimensions of suicidality may be more commonly experienced in daily life. 
Passive suicidality deals with vague thoughts of suicide, such as thoughts of death and 
feelings that life is not worth living. Having ‘thoughts of death’ is itself part of the DSM-5 
criteria for MDD (American Psychiatric Association, 2013) and such passive suicidality is 
associated both with active suicidal ideation and with suicidal acts themselves (Steer et al., 
1993). A high-frequency intra-day measure of passive suicidal thoughts may therefore allow 
for a more nuanced measurement of suicidality in MDD. 
1.2.3. Tiredness Dynamics. Tiredness is the most prevalent symptom of MDD, with 78% of 
patients reporting at least moderate daily levels (Vaccarino et al., 2008). In healthy 
individuals, subjective tiredness has a distinctive diurnal time-trend: a V-shape pattern, where 
levels decline from morning to mid-day (where they reach a trough), and then rise steadily 
until reaching a peak in the late evening time (Dockray et al., 2010; Stone, et al., 1996; Stone 
et al., 2006). However, no study has yet investigated the diurnal dynamics of tiredness in 
MDD. Given that the diurnal pattern in tiredness appears to be an integral part of healthy 
experience, understanding how the pattern differs in MDD may provide a new insight into the 
nature of this central symptom.  
1.3. The Present Study 
 Little work has investigated the intra-day dynamics of MDD symptoms other than 
affect. Furthermore, work on affect dynamics has largely focused on instability and 
  
variability, neglecting the importance of diurnal time-trends in experience. In this study we 
therefore aimed to extend prior work by providing a fine-grained ESM account of the within-
day time-trends, instability, and variability of affect, self-esteem, passive suicidality, and 
tiredness in MDD. We examined multiple facets of the intra-day dynamics of affective, 
cognitive, and somatic symptoms in tandem in order to improve our overall understanding of 
the daily experience of MDD by providing (1) a phenomenological insight into how 
symptoms are experienced across the day in MDD and (2) an understanding of the 
differences between psychologically ‘healthy’ and ‘unhealthy’ patterns of experience, and as 
such potential targets for treatment.  
 Given the lack of previous research, much of this study is exploratory. For example, 
we had no specific hypotheses in relation to self-esteem time-trends or tiredness dynamics in 
MDD. Nevertheless, based on the evidence that has been discussed, we hypothesized the 
following: 
(1) NA, self-esteem, and passive suicidality would exhibit significantly higher levels of 
variability and instability in MDD.  
(2) Affect and passive suicidality would exhibit significantly more pronounced ‘morning-
worse’ diurnal time-trends in MDD.   
2. Method  
2.1. Participants 
  
Participants with MDD were recruited via psychiatric treatment centers across Dublin, 
Ireland.
1
 Individuals attending these centers were invited to partake if they were currently 
experiencing a MDD episode (as per DSM criteria). Control participants were recruited 
through an advertisement placed in a national newspaper.
2
 Controls were screened via 
telephone interviews and were not permitted to partake if they had any psychiatric history. 
The age range of participants was 18-70 years. Outpatients and control participants received 
reimbursement for travel expenses; there was no other monetary compensation for 
participation. Ethical approval was granted from the relevant ethical review boards. 
Participants provided informed consent and then underwent a one-to-one briefing 
session with a trained researcher. This involved detailed instructions on completing the ESM 
protocol. Participants also completed the diagnostic Mini International Neuropsychiatric 
Interview (MINI Plus 5.0.0, Sheehan et al., 1998), Hamilton Depression Inventory (Ham-D, 
Hamilton, 1960), Beck Depression Inventory (BDI, Beck et al., 1961), Rosenberg Self-
Esteem Scale (RSE, Rosenberg, 1965), Beck Scale for Suicidal Ideation (BSS; Beck et al., 
1988), a demographic questionnaire, and other relevant psychometric assessments (see 
appendices, which can be viewed online as supplemental material). Case-consensus 
conferences with a consultant research psychiatrist and chart reviews were conducted to 
verify diagnoses.  
2.2. Experience Sampling Procedure 
Following the briefing session, participants underwent 6 consecutive days of the 
ESM. A signal-contingent design was employed, with a sampling rate of 10 signals per day. 
                                                          
1
The centers involved in this research were St. John of God’s Psychiatric Hospitallier Services, St. Partick’s 
University Psychiatric Hospital, St. Vincent’s University Hospital and Glenmalure Community Day Centre in 
Dublin, Ireland. 
2
 Irish Times Health Supplement, 2013, February 26
th
, p. 8. 
  
This signal frequency allowed a fine-grained analysis of diurnal symptom rhythms and 
fluctuations between moments, while the spacing of signals captured experiences that 
spanned the day – morning, afternoon, and evening.  
On each ESM day, participants were instructed to go about their daily activities as 
normal, while wearing a pre-programmed wristwatch between the hours of 8am and 
10:30pm. During each of ten 90-minute intervals over the day, the wristwatch paged 
participants. On hearing the pager, participants were instructed to complete a 2-5 minute 
questionnaire on their immediate symptom levels. The day following the ESM period, 
participants underwent a de-briefing session where they returned their completed ESM 
materials, which were checked for validity and rates of completion. 
A pen-and-paper ESM was used to facilitate ease of use and open-ended answers 
(results of the latter are not included here). With pen-and-paper ESM modes, there is a risk 
that surveys could be completed at a later time and therefore measure retrospective rather 
than momentary feelings (Stone et al., 2002). To reduce the likelihood of this, the signal-
contingent pen-and-paper method asks participants to record the current time (as per their 
ESM wristwatch) at the end of each momentary report. As the time at which participants were 
paged or ‘beeped’ varied across hours and days, it was improbable that participants could 
guess correctly at a later stage the time at which each beep occurred. Therefore, responses 
were validated by matching the self-reported time of completion of each survey with the pre-
programmed time of each beep. The semi-random design of the signal-contingent ESM paper 
mode has been shown to be as valid as computerized versions (Green et al., 2006; Houben et 
al., 2015; Palmier-Claus et al, 2011). 
2,548 momentary surveys were collected. In line with previous ESM studies on MDD 
and suicidal samples, responses given outside of 25 minutes from the time of the signal were 
  
excluded from analysis (Peeters et al., 2006; Husky et al., 2014). Participants who did not 
provide enough data to ascertain diurnal trends (at least 30% of reports per day over at least 2 
days) were excluded from the data. These exclusion criteria resulted in a loss of 313 reports 
(117 control and 196 MDD reports) and two individuals (MDD participants) with less than 
the recommended number of reports. The remaining sample consisted of 2,231 episodes: 
1,205 control episodes and 1,026 MDD episodes. 
2.3. ESM Measures 
The ESM questionnaire was designed to capture key clinical dimensions of daily 
experience in MDD. Each item was measured via a Likert scale, ranging from 1 (not at all) to 
7 (very). Multilevel exploratory factor analysis with oblique rotation was conducted using 
Mplus (version 8). This suggested that the ESM items were measuring distinctive symptom 
constructs.  
2.3.1. Affect.  
Items from previous research were used to measure affect (Peeters et al., 2006; Stone et al., 
2006). Individuals were asked to rate their current levels of  ‘happy’, ‘relaxed’, ‘interested’, 
and ‘enjoying myself’ (PA items) and ‘irritated’, ‘down’, ‘anxious’, ‘tense’, ‘ashamed,’ and 
‘guilty’ (NA items). Multilevel exploratory factor analysis with oblique rotation on raw affect 
scores yielded a two-factor solution according to the Kaiser criterion (Eigenvalue > 1) at both 
the between and the within-person levels. PA item loadings on Factor 1 (PA factor) ranged 
from 0.78 – 0.99 at the between-person level and 0.43 – 0.82 at the within-person level. NA 
item loadings on Factor 2 (NA factor) ranged from 0.74 – 0.95 at the between-person level 
and 0.30 – 0.91 at the within-person level. NA items were averaged to form an ESM NA 
score (between-person composite reliability = 0.84; within-person composite reliability = 
0.50), while PA items were averaged to form an ESM PA score (between-person composite 
  
reliability = 0.82; within-person composite reliability = 0.46). 80.3% / 44.4% of the total 
between/within-person variance in the PA items was explained by the PA factor, and 82.9% / 
39.5% of the between/within-person variance in NA items was explained by the NA factor. In 
line with previous literature, PA and NA scores appeared to measure separate constructs 
(Watson and Clark, 1997). Correlations between PA and NA scores were moderate: r = 0.51, 
p <0 .001 for MDD participants, r = 0.59, p < 0.001 for controls. 
2.3.2. Self-esteem.  
Items by Thewissen et al. (2011) were used to measure self-esteem in daily-life: ‘I like 
myself’, ‘I am a good person’, ‘I feel useless’, (reverse-scored) and ‘I am a failure’ (reverse-
scored). Multilevel exploratory factor analysis with oblique rotation conducted on raw scores 
of these items identified one factor with an Eigenvalue > 1. This factor accounted for 71.4% 
of between-person variance and 31.6% of within-person variance. The four items had strong 
loadings (with negative statements reverse-scored, between-person loadings were 0.82 - 0.99 
and within-person loadings 0.35 - 0.72). These items were summed to create the ESM self-
esteem measure, with good reliability (between-person composite reliability = 0.78, within-
person composite reliability = 0.44). Intra-individual means in this ESM self-esteem item 
correlated strongly (r = 0.87, p < 0.001) with the RSE, a well-established 10-item scale of 
global self-esteem level (Rosenberg, 1965).  
2.3.3. Suicidality.  
ESM research has found an aversion effect to extreme or negatively valenced items, 
including those directly assessing active suicidality (Husky et al., 2014; Nock et al., 2009, 
Palmier-Claus et al., 2011). With the aim of obtaining a more nuanced measure of within-day 
suicidality, momentary passive suicidality was assessed via the averaged sum of the more 
moderately worded items ‘I feel that life is worth living right now’ (reverse scored) and ‘I am 
  
having thoughts about death right now’. These were adapted from similar items in the BSS, a 
well validated 19-item self-report of current suicidal ideation (Beck et al., 1988). Participant 
mean levels of the ESM passive suicidality item correlated very well with BSS scores (r = 
0.63, p < 0.001) and the BDI suicide item (r = 0.63, p < 0.001). This measure was thus 
designed so as to detect more variation than extremely negatively valenced items. This 
strategy was moderately successful: 85% of MDD reports and 37% of control reports 
reported at least some level of passive suicidality (scoring > 1). Alongside this measure, 
participants were asked the more negatively valenced ‘Since the last beep, have you had 
thoughts about physically harming yourself in any way?’ to measure directly active suicidal 
and self-harm ideation. As expected, this item was endorsed relatively infrequently: 3% of all 
MDD reports answered yes to this question (33 reports in total, nested in 12 individuals), 
while no control reports endorsed this item. 
2.3.4. Tiredness.  
In line with previous literature (Stone et al., 2006), tiredness was seen to be a factor 
independent of cognitive-affective items, and was considered as a single item ‘I feel tired’. 
2.4. Statistical Analysis 
As the data had a hierarchical structure, multilevel random-effects modeling was 
employed. Independence of data points was not assumed at the beep or day level, and within- 
and between-person effects were estimated simultaneously. Models for each analysis are 
presented beside their corresponding results. All effects were modeled as random effects 
(where intercepts and slopes are allowed to vary) using the “MIXED” command in STATA/SE 
version 13 (StataCorp). The residual-error structure used in all models (aside from variability 
models) was unstructured covariance, which estimates all associations between error terms. 
Robust standard errors were not used in regression analysis, due to issues with using these on 
  
small-moderate samples (Imbens and Kolesar, 2016). In these models, MDD = group status (a 
binary variable where 1 = MDD group and 0 = control group); i = ESM report/beep level; j = 
day level; and k = individual level. β is the fixed regression coefficient.  
3. Results 
3.1. Participant Characteristics 
MDD participants completed an average of 33.1 valid ESM questionnaires per 
individual, compared to an average of 36.5 for controls. The difference between these was 
non-significant, t(62) = 1.03, p = 0.31. There were no significant differences between MDD 
and control groups on most demographic characteristics (see appendix A; appendices are 
available to view as online supplemental material). The exception was gender: there were 
significantly more females in the control group. All analyses therefore adjust for gender. 
In terms of the MDD group, average scores on the BDI (23) and Ham-D (18.3) 
indicated a moderate-severe sample (see appendix B). The MDD sample consisted mostly of 
inpatients (77%; see appendix C). However, most inpatients had at least two days leave from 
hospital during their ESM week (97%), allowing for a comparison with outpatient 
participants. Thirty-three percent of the MDD sample had attempted suicide at least once in 
the past, while over half (58%) reported some suicidal ideation. The majority of the MDD 
participants (89%) had recurrent depression and 30% had a secondary diagnosis of an anxiety 
disorder. 90% of the MDD sample were on anti-depressant medication: 12 individuals were 
prescribed serotonin-norepinephrine reuptake inhibiters (SNRIs), 10 were prescribed 
selective serotonin reuptake inhibiters (SSRIs), 3 were prescribed trycyclics (TCAs) and 3 
atypical antidepressants (e.g. mirtazapine). 
3.2. Symptom Variability  
  
3.2.1. Between- and within-person variance.  
Intercept only random-effects models were fitted for each symptom individually to establish 
the symptom variance accounted for by between- and within-person levels. Table 1 presents 
the intraclass correlation coefficients (ICCs) for each symptom (for example, the ICC for NA 
in the total sample is 0.75, meaning that 75% of the variance is at the between-person level 
and 25% is at the within-person level; for the MDD group alone, the ICC is .66 and for the 
control group the ICC is .53). As shown in Table 1, all ESM symptom measures exhibited 
significant between-person variance (Var 
 
u
k
), suggesting significant variability in all 
symptoms across the full sample of participants. This provides evidence against floor and 
ceiling effects.  
3.2.2. Variability. 
 Next, within-person variances for control [var (
 
e
ik
C
)] and MDD [var (
 
e
ik
MDD
)] groups were 
estimated to establish if these differed significantly. Random effects models with 
heteroskedastic errors were fitted for each symptom (Gutierrez, 2008).
3
 The intercepts in 
these models were fixed so that the only random effect at level 1 was group (control or 
MDD). This model is articulated as follows: 
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3
 More information on this model (including STATA commands) can be found at the following UCLA Statistical 
Consulting Group webpage: https://stats.idre.ucla.edu/stata/faq/how-can-i-fit-a-random-intercept-or-mixed-
effects-model-with-heteroskedastic-errors-in-stata/ 
  
The significance of the difference between control and MDD within-person variances  
[var
 
e
ik
MDD e
ik
C ] was thus established. As shown in Table 1, all five symptoms had 
significantly different variances between-groups. The MDD group had significantly higher 
variances in all symptoms with the exception of tiredness, where the control group had higher 
variability (displayed in Figure 1, row a).  
3.3. Symptom Instability 
To establish symptom instability, successive squared differences between moments 
were calculated. These were calculated only on moments within days; the differences 
between evening-morning symptom levels were not included in the analysis. Successive 
squared difference values were then square root transformed, so that they reflected the size of 
the absolute change or successive difference ( |D|) in symptom levels between measurement 
occasions. A two-step regression analysis was conducted to establish group differences in 
instability.  
Step 1. In this step, MDD group was entered as the predictor variable with gender and 
age as controls.  
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Average scores for MDD and control participants are displayed in Figure 1, row (b). 
Estimates from the multilevel analyses of scores between moments are displayed in Table 2. 
Results from this step were largely as predicted. Significantly higher instability was found in 
MDD participants in all symptoms, with the exception of tiredness where there was no 
significant difference between groups. NA instability showed the greatest difference between 
groups, with fluctuations between moments being almost half a point higher in the MDD 
group (B = .476; SE = .074; p < 0.001). PA, self-esteem and suicidality all showed between-
  
moment fluctuations that were on average 0.27 – 0.28 points higher in the MDD group (p < 
0.001 in each case). 
 Step 2. In the second step the intra-individual mean of the predictor symptom was 
entered as a covariate in the model, as some have argued that it is important to distinguish 
symptom instability from overall severity (Ebner-Priemer, Eid, Kleindienst, Stabenow and 
Trull, 2009):  
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PA and suicidality instability no longer displayed significant associations with MDD 
in this step (p > 0.05; see Table 2). Thus, it appears that the relationship between instability in 
these symptoms and MDD was explained by symptom level. Both NA and self-esteem 
instability retained significant associations with MDD (for NA: B = .198; SE = .084; p < 0.02; 
for self-esteem: B = .172; SE = .073; p < 0.02). 
3.4. Diurnal time-trends in symptoms 
3.4.1. Modeling time-trends.  
As quadratic relations have been identified in numerous studies on diurnal time-trends of 
affect in MDD and tiredness in the general population (e,g. Peeters et al., 2006; Stone et al., 
2006), a two-step approach was used whereby the quadratic term was first tested. We 
therefore test whether modeling non-linear trends produces a better fit to the study data 
(indicated by a statistically significant quadratic term) before modelling a linear relationship. 
Between-group differences in diurnal trends were investigated by fitting interaction terms 
between MDD and the linear (MDD*Time) and quadratic time term (MDD*Time
2
). Time-
trend effects were then modelled for each group separately using the below models. Time of 
day (Time) was treated as a continuous variable in these. 
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 Where no evidence for a quadratic trend was identified, a linear term was tested.  
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3.4.2. Results.  
Figure 2 depicts the diurnal time-trends identified in each group, while Tables 3 and 4 
summarize the findings in relation to these time-trend regressions. The interaction terms for 
NA did not reach significance (p > 0.10), indicating there were no statistically significant 
differences between-groups in this diurnal trend. As shown in Table 4, NA did not display a 
significant time-trend in either the MDD or control group. PA and tiredness both showed 
significant between-group differences in their diurnal time-trends. In PA, there were 
significant linear (B = 0.175; SE = 0.054; p = 0.001) and quadratic (B = -0.016; SE = 0.005; p 
= 0.001) interaction terms, indicating significant differences between-groups. As shown in 
Figure 2, the control group displayed a linear pattern in PA, which continued to rise from 
morning through late evening. The MDD group displayed an inverted-U (quadratic) PA time-
trend, which rose from morning into the afternoon, before dipping slightly later in the 
evening.  
Tiredness also displayed significantly different patterns of change between groups, 
indicated by the significance of the quadratic interaction term (B = -0.015; SE = 0.007; p < 
0.05). Although the normative V-shaped quadratic pattern was identified in both MDD and 
control groups, the V-shape was significantly more pronounced in the control group. As seen 
in Figure 2, tiredness in MDD had a much flatter shape over the day.  
The linear interaction term for passive suicidality (B = -0.012; SE = 0.007; p < 0.10) 
and the quadratic interaction term for self-esteem (B = -0.004; SE = 0.003; p < 0.10) were of 
  
trend-level significance, suggesting somewhat different diurnal patterns of change across 
groups. As shown in Table 4, group-specific time-trend analyses revealed a significant and 
negative linear time-trend in suicidality in the MDD group (B = -0.018; SE = 0.006; p < 
0.005), but not in the control group (B = -0.006; SE = 0.004; p = 0.089), while there was a 
significant quadratic trend in self-esteem in MDD (B = -0.006; SE = 0.002; p =0.017), but 
non-significant quadratic and linear trends in the control group. Thus, as shown in Figure 2, 
there was evidence to suggest a subtle morning peak in passive suicidality levels and 
inverted-U diurnal trend in self-esteem in the MDD group.  
4. Discussion 
All five symptom constructs displayed distinct intra-day profiles in MDD when 
compared to those of healthy controls. Cognitive-affective symptoms exhibited significantly 
increased variation in the daily life of individuals with MDD. In contrast, the one somatic 
symptom studied, tiredness, exhibited significantly decreased within-day variation in MDD. 
This indicates that as well as the overall severity of symptoms, symptom dynamics also 
define the daily experience of MDD and separate it from healthy psychological experience.  
4.1. Increased variability and instability in cognitive and affective symptoms 
Negative affect (NA), positive affect (PA), self-esteem, and passive suicidality all 
exhibited large and frequent within-day fluctuations in the MDD group. In line with a large 
body of previous work (Houben et al., 2015), NA showed the greatest difference between 
groups in instability and variability. Unlike most previous studies, however, increased 
instability and variability were also found in PA in MDD (albeit to a lesser extent than NA). 
This supports arguments for the importance of PA dynamics in depression (Gruber et al., 
2013). MDD was also strongly associated with self-esteem variability and instability. This is 
in keeping with earlier work on self-esteem variability in MDD (Franck and De Raedt, 2007) 
  
and argues against more recent work positing that self-esteem variability is not a significant 
aspect of MDD (Sowislo et al., 2014). Increased variability and instability in passive 
suicidality was another feature of MDD symptom dynamics. Previous work has shown an 
association between increased day-to-day instability in suicidality and past suicide attempts 
(Witte et al., 2005; Witte et al., 2006). Lability in suicidal thoughts may therefore prove to be 
an important factor in understanding suicide risk. 
The relationship between MDD and symptom instability differed somewhat across 
cognitive-affective symptoms. Instability in NA and self-esteem had strong associations with 
MDD that were independent of the severity (mean-levels) of these symptoms. However, 
mean symptom levels appeared to explain the relationship between MDD and instability in 
PA and suicidality: as the severity of daily passive suicidality increased, so did instability in 
the intensity of such thoughts, while as overall PA levels decreased, PA instability increased. 
4.2.. Diurnal time-trends in positive affect, tiredness, suicidality, and self-esteem 
Diurnal time-trends were identified in PA, tiredness and, to some degree, passive 
suicidality and self-esteem. Although NA exhibited high levels of instability and variability in 
MDD, it did not display a significant diurnal time-trend. This was surprising, as a significant 
‘morning worse’ NA trend is a feature of previous conceptualizations of diurnal mood 
variation in MDD (Leibenluft et al., 1992; Peeters et al., 2006). Instead, the morning-worse 
MDD pattern was manifest in PA.  
PA in MDD displayed significantly more diurnal variation than controls: it had an 
inverse-U shape (compared to a linear trend in controls) with a steeper overall increase from 
morning lows to evening highs. This pronounced diurnal pattern found in MDD PA is at odds 
with the findings of Murray (2007), where depression was associated with a weakened and 
flatter diurnal PA pattern. Instead, our findings replicate the more pronounced quadratic 
  
MDD PA pattern found in Peeters et al. (2006). The finding that ‘morning-worse’ mood in 
MDD is expressed via PA lows rather than NA highs is in keeping with recent research, 
which also found the ‘morning-worse’ depression pattern to be much more pronounced in PA 
than NA (Daly et al., 2011). Again, this emphasizes the prevalence and importance of PA 
dynamics in MDD.  
To a lesser extent, suicidality and self-esteem also displayed morning-worse patterns 
in MDD. In the MDD group, self-esteem displayed an inverse-U shape, but to a much lesser 
extent than PA. In suicidality, a significant linear trend with a morning peak was detected in 
the MDD group. This is similar to the morning peaks identified in previous research on 
suicidal acts (Preti and Miotto, 2001; Williams and Tansella, 1987). However, the findings in 
relation to the time-trends of self-esteem and suicidality should be interpreted with caution: 
as can be seen in Figure 2, both trends were very subtle, and although the trends were 
significant in the MDD group, neither were found to be significantly different from those of 
control participants.  
Tiredness was uniquely defined by decreased diurnal dynamics in MDD. The control 
group had higher variances, a more pronounced V-shaped diurnal pattern, and a steeper 
overall increase from morning to evening levels than the MDD group. Relative to controls, 
individuals with MDD experienced tiredness at a high and constant level during the day, with 
less of a mid-day nadir in levels. It appears that individuals with MDD do not feel relatively 
more tired at night compared to the rest of their day. This diurnal pattern could help to 
explain the apparently paradoxical MDD experience of low levels of daily energy and 
motivation, yet difficulties in getting to sleep in the evening time.  
4.3. Theoretical differences between variability, instability, and diurnal time-trends 
  
It is important to briefly consider the theoretical differences and relationships between 
the dynamics measured, and what they can tell us about the nature of the symptoms studied. 
Variability refers to how much symptoms deviate from average levels over the course of the 
day. Variability can be expressed in a number of ways: gradual changes throughout the day, as 
well as significant changes from one moment to the next (i.e. instability). Therefore, although 
the three concepts measured in this study are related (if one has high instability or a 
pronounced diurnal time-trend, they will also have high variation from mean levels and thus 
high variability), they are not the same thing.  
For example, decreased variability – but not instability – was found in tiredness in the 
MDD group. It appears that the difference one feels in tiredness levels from one moment to 
the next is not as important as a more gradual variation in overall levels across the day. This 
gradual variation in tiredness was expressed as a systematic diurnal time-trend. This study 
emphasizes that it is important to measure multiple aspects of daily symptom dynamics. 
Variability tells us the extent to which symptom levels change across the day, while other 
aspects (instability and time-trends) give important phenomenological information on how 
this variation is experienced.  
4.4. Possible mechanisms underlying symptom dynamics 
 This study’s aim was to provide a descriptive account of the dynamics of MDD 
symptom constructs, not to explain why or how these symptoms fluctuate as they do across 
the day. Nevertheless, we tentatively suggest two possible mechanisms underlying symptom 
dynamics: difficulties in emotion regulation and dysregulation in biological circadian 
rhythms. 
A common feature across cognitive-affective symptoms in MDD is emotion 
regulation deficits and a lack of cognitive control (Joormann and Vanderlind, 2014). Such 
  
deficits result in difficulties moderating cognitive and affective reactions to both external 
events and internal thoughts (such as suicidal cognitions and negative self-thoughts), and 
could therefore lead to the frequent and amplified fluctuations found in affect, self-esteem, 
and suicidality.  
 The finding that tiredness did not show increased variability or instability in MDD 
suggests that this symptom is relatively unreactive to thoughts or external events. Previous 
work has found that, unlike other subjective experiences, diurnal variation in tiredness is not 
dependent on the activities an individual is engaged in (Stone et al., 1996; Stone et al., 2006). 
Instead, tiredness dynamics may be more influenced by endogenous circadian variation in 
biological systems. The HPA axis plays an important role in regulating sleep-wake cycles and 
energy mobilization and thus influences subjective feelings of fatigue and tiredness 
throughout the day (Harris et al., 2015; Tops et al., 2006). A flatter slope in cortisol output 
has been identified in individuals with depression (Stetler and Miller, 2005). HPA axis 
dysregulation could therefore contribute to the similarly flatter diurnal rhythm found in MDD 
tiredness.  
Likewise, the MDD ‘morning worse’ diurnal trend in affect has traditionally been 
thought to be due to a dysregulation of circardian rhythms in biological processes, such as 
HPA axis activity and melatonin secretion (Hall et al., 1964; Moffot et al., 1994). More recent 
research has found that morning lows in affect are linked with lower than average cortisol 
levels in the hours after waking (Daly et al., 2011). Experimentally administered cortisol has 
been found to induce feelings of energy and vigor (Plihal et al., 1996; Tops et al., 2006). 
Energy, alertness, and vigor are aspects of the construct of PA (Watson and Clark 1997). 
Therefore, it makes sense that the affective correlates of low morning cortisol levels would be 
expressed via a lack of PA rather than intense NA – and thus a morning-worse pattern in PA, 
  
rather than NA. Uncovering the mechanisms that underlie MDD symptom dynamics will be a 
fruitful area of future research. 
4.5. Limitations 
This study has a number of limitations. Firstly, the majority of the MDD sample was 
receiving pharmacotherapy. Including patients on medication resulted in a sample that 
reflects the psychiatric MDD population. Nonetheless, it may be the case that the effects of 
anti-depressant medication drove the group differences in symptom dynamics found in this 
study, rather than depression per se. However, research has found imipramine to reduce the 
variability of quality of life ESM reports in individuals with MDD (Barge-Schaapveld and 
Nicolson, 2002), suggesting that the differences found between groups in the current study 
may be even more marked in a non-medicated sample. Further research is required to 
establish the differential effect of anti-depressant treatment on the dynamics of different 
MDD symptoms. 
The MDD sample also consisted of a mix of inpatient and outpatient participants. We 
argue that these samples are comparable, since outpatients were treated at the same facilities 
as inpatients during the day, were taking the same medications, and had similar levels of 
depression. Additionally, inpatients took at least two days’ leave from their hospital stay 
during the ESM week. 
The passive suicidality measure has not been used in ESM research previously. It is 
therefore unknown whether it is a good proxy for more active suicidal thoughts and 
behaviors. However, it correlated strongly with both BDI and BSS assessments, suggesting 
that it was tapping into subjective suicidality. This measure was designed to capture more 
variability than negatively valenced suicide items and was endorsed to a far greater extent 
than the question directly assessing self-harm and suicide. However, although 85% of MDD 
  
ESM reports and over a third of control reports reported at least some level of passive 
suicidality, controls nevertheless displayed very low scores on this measure, which may have 
curtailed the variability that could be identified in this group.  
Likewise, the case-control design meant that the control group exhibited much lower 
NA and much higher self-esteem scores than the MDD group. As with suicidality, it may be 
the case that floor and ceiling effects reduced the ability to detect variation in these symptoms 
in the control group. We argue that the results found in these symptoms are still meaningful 
because in analyses where mean levels were controlled for (i.e. instability analysis), 
significant differences remained across groups. This indicates that mean levels cannot fully 
explain the differences found between MDD and control groups in self-esteem and NA 
instability. Nonetheless, a recommendation for further research is to produce more fine-
grained measures of suicidality, NA and self-esteem that can detect more variability, by using 
more items, less negatively worded items and response scales that allow for small variations 
to be identified (such as visual analogue scales). Including psychiatric as well as healthy 
control groups may also allow a more nuanced exploration of daily dynamics in MDD 
experience.   
4.6. Conclusions and future directions 
This study provides a systematic, multidimensional exploration of five subjectively 
experienced MDD symptom constructs: PA, NA, self-esteem, suicidality, and tiredness. We 
found evidence that the MDD group differed from the control group across all symptoms 
investigated, each of which showed evidence of distinct diurnal time trends and/or patterns of 
variability and instability in MDD. This study sets the stage for additional ESM studies to test 
these relationships further and explore the dynamics of an even broader range of MDD 
experiences and behavior. Longitudinal designs hold particular promise, as the usefulness of 
  
this intra-day dynamics approach will ultimately lie in its predictive power in forecasting 
diagnoses, treatment, and recovery (van de Leemput et al., 2014; Wichers et al., 2010).  
Individual depression symptoms have recently been found to be associated with 
different risk factors, treatment responses, biomarkers and effects on psychosocial 
functioning (see review by Fried and Nesse, 2015). Research suggests that different within-
day dynamics in affect also have differential associations with psychological functioning 
(Gruber et al. 2013), biological functioning (Daly et al., 2011; Daly et al., 2014; Peeters et al., 
2003) and treatment outcomes (Wichers et al., 2012). It is likely therefore that dynamics in 
the other depression symptoms explored in this study – self-esteem, suicidality and tiredness 
– also play distinct roles in MDD outcomes. Broadening the focus of depression research to 
include within-day symptom dynamics (alongside symptom severity) will help us to 
understand and ultimately treat more effectively the daily experience of MDD.  
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Appendix A 
  
Demographic and ESM Information for MDD and Healthy Control Groups  
Variable MDD Healthy Control p 
Demographics      
N 31  33   
% Women 42%  70%  =0.03 
Age (M, SD) 44.4 (12.1) 41.2 (14.4) >0.05 
Race: caucasian 100%  97%  >0.05 
Education level completed
a  
 4.32 (1.22) 4.97 (1.32) >0.05 
Psychiatric Family History 57%  48%  >0.05 
Household income above €40,000 56%  61%  >0.05 
In a relationship 54%  64%  >0.05 
Single 30%  27%  >0.05 
Widowed 3%  0%  >0.05 
Divorced/separated 13%  9%  >0.05 
Has Children 70%  48%  >0.05 
No. Children (M, SD) 1.96 (1.02) 1.5 (1.39) >0.05 
Currently employed 58%  77%  >0.05 
ESM information      
Before validation      
Total completed prompts 1226  1322   
N participants 33  33   
Completed prompts per participant (M, SD) 37.1 (15.7) 40.1 (12.2) >0.05 
After validation      
Total completed prompts 1030  1205   
N participants 31  33   
Completed prompts per participant (M, SD) 33.1 (13.6) 36.5 (12.9) >0.05 
a
 Education level is rated on a 6-point scale, where 1 = primary school; 2 = some high school; 
3 = complete high school; 4 = post-high school diploma/certificate; 5 = university 
undergraduate degree; 6 = university post-graduate degree. 
Note. p values refer to independent samples t-tests of between-group differences in each 
variable. 
  
Appendix B  
Trait Scale Scores for MDD and Healthy Control Groups 
 MDD Healthy Control   
Scale M SD M SD p 
1. Beck Depression Inventory 23 (9) 3 (3.1) < 0.001 
2. Hamilton Rating Scale for Depression 18.3 (6) 1.8 (2) < 0.001 
3. Beck Scale for Suicidality 7.1 (7.8) 0.3 (1.1) < 0.001 
4. Rosenberg Self-Esteem 24.4 (6.1) 34.7 (4.1) < 0.001 
5. Global Assessment of Functioning 52.4 (9.8) 91.3 (6.1) < 0.001 
6. Mean ESM negative affect score  2.9 (1.2) 1.5 (0.5) < 0.001 
7. Mean ESM positive affect score 3.6 (0.9) 4.9 (0.9) < 0.001 
8. Mean ESM self-esteem score 4.6 (1.3) 6.2 (0.5) < 0.001 
9. Mean ESM tiredness score 4.3 (1.2) 3 (1.2) < 0.001 
10. Mean ESM suicidality score 2.4  (0.8) 1.4 (0.4) < 0.001 
Note. References with validity and reliability information for the above scales are as follows: 
(1) Beck, Steer, and Carbin, 1988; (2) Hamilton, 1960; (3) Beck, Steer, and Ranieri, 1988; (4) 
Rosenberg, 1965; (5) Jones, Thornicroft, Coffey, and Dunn, 1995; Measures 6 – 10 are 
aggregates of ESM intra-individual symptom scores from across the sampling period. p 
values refer to independent samples t- tests of between-groups differences in each variable. 
 
  
Appendix C 
Clinical characteristics of MDD group. 
Variable MDD (n=31) 
First episode 11%  
Inpatient 77% 
Of inpatients: took leave 94% 
Positive family psychiatric history 57%  
Suicide attemptor 
 
33%  
Suicide ideator (BDI)
a 
58%  
Secondary anxiety disorder 36% 
On antidepressant medication 90% 
a 
As measured via the suicide item of the Beck Depression Inventory.  
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Figure 1. Symptom variability (variances; row a) and instability (average symptom fluctuations 
between moments, the squared root of the successive squared difference between reports; row b) for 
MDD and control participants. Error bars are 95% confidence intervals.  
 
Figure 2. Diurnal symptoms patterns for MDD and control groups. Row (a) is raw symptom scores 
for each time of day for each group. Error bars are 95% confidence intervals. Row (b) depicts 
symptom time-trends (regression lines) for control and MDD groups. X-axis is ESM symptom level 
(on a Likert scale from 1 – 7). Y-axis is time of day (from 8:30 am to 10:00 pm), where each time of 
day refers to the mid-point of each 90-minute ESM ‘beep’ block (each participant was beeped once 
during each block) 
  
 
Table 1. Total Between-Person Variance (Var 
 
u
k
), Differences Between MDD and Control 
Within-Person Variance [Var
 
e
ik
MDD e
ik
C ], and Intraclass Correlation Coefficients (ICC) for 
ESM Symptom Measures for the Total Sample and for MDD and Control Groups Separately 
Symptom Var 
 
u
k
[95% CI] Var
 
e
ik
MDD e
ik
C [95% CI]  ICC 
Total 
ICC 
MDD 
ICC 
Control 
Negative 
Affect 
1.15 [0.96, 1.38] 0.45 [0.39, 0.53] 0.75 .66 .53 
Positive Affect 1.09 [0.91, 1.30] 0.17 [0.10, 0.29] 0.62 .50 .52 
Self-Esteem 1.27 [1.06, 1.52] 0.22 [0.19, 0.25] 0.88 .84 .63 
Suicidality 0.81 [0.68, 0.97] 0.16 [0.13, 0.19] 0.75 .69 .50 
Tiredness 1.30 [1.09, 1.56] -0.39 [-0.23, -0.68] 0.49 .45 .39 
 
Table 2. Association Between MDD Group Status and Symptom Instability Before (Step 1) 
and After (Step 2) Adjustment For Intra-Individual Mean Symptom Levels  
  
Symptom B SE p 
Step 1: 
Negative Affect |D| 
   MDD 0.476
*** 
0.074 < 0.001 
Positive Affect |D| 
   MDD 0.276
***
 0.060 < 0.001 
Self-Esteem |D| 
   MDD 0.279
***
 0.058 < 0.001 
Suicidality |D| 
   MDD 0.272
***
 0.058 < 0.001 
Tiredness |D| 
   MDD 0.100 0.112 0.371 
Step 2
a
    
Negative Affect |D|    
   MDD 0.198
**
 0.084  0.018 
Positive Affect |D|    
   MDD 0.119 0.078  0.128 
Self-Esteem |D|    
   MDD 0.172
**
 0.073  0.019 
Suicidality |D|    
   MDD 0.082 0.063 0.193 
Tiredness |D|    
  
   MDD -0.033 0.137 0.810 
Note. All models adjust for age and sex. |D| = Successive difference score between reports. 
MDD = binary variable where 1 = MDD and 0 = control group. 
a 
Includes control for intra-individual mean symptom level. 
***p < 0.001; **p < 0.02. 
 
Table 3. Multilevel Estimates of Interaction Effects Between MDD Group Status (MDD) and 
Linear and Quadratic Time of Day Trends 
Symptom B SE p 
Negative Affect    
    Time*MDD -0.003 0.010 0.765 
    Time
2
*MDD --- --- --- 
Positive Affect   
    Time*MDD 0.175
** 
0.054 0.001 
    Time
2
*MDD -0.016
**
 0.005 0.001 
Self-Esteem   
    Time*MDD 0.062
*
 0.031 0.045 
    Time
2
*MDD -0.004
†
 0.003 0.095 
Tiredness   
    Time*MDD 0.134 0.084 0.110 
    Time
2
*MDD -0.015
*
 0.007 0.039 
Suicidality   
    Time*MDD -0.012
†
 0.007 0.078 
    Time
2
*MDD --- --- --- 
Note. A quadratic model (Time
2
) was firstly tested. Where no evidence for a quadratic model 
was identified a linear model (Time) was tested.  Models adjust for gender and age. Time is 
treated as a continuous variable.  
**p < 0.01; *p < 0.05; 
†
p < 0.10. 
 
Table 4. Multilevel Estimates of Linear and Quadratic Time of Day Effects on Symptoms in 
MDD and Healthy Control Groups. 
  
 
Symptom MDD Healthy Control 
 B SE p B SE P 
Negative Affect      
    Time -0.009 0.009 0.292 -0.006 0.005 0.175 
    Time
2
 --- --- --- --- --- --- 
Positive Affect     
    Time 0.203
***
 0.046 <0.001 0.028 0.007 <0.001 
    Time
2
 -0.016
***
 0.004 <0.001 --- --- --- 
Self-Esteem     
    Time 0.075
**
 0.029 0.009 -0.003 0.003 0.440 
    Time
2
 -0.006
*
 0.002 0.017 --- --- --- 
Tiredness     
    Time -0.172
**
 0.061 0.005 -0.304
***
 0.057 <0.001 
    Time
2
 0.017
***
 0.005 0.001 0.032
***
 0.005 <0.001 
Suicidality     
    Time -0.018
**
 0.006 0.003 -0.006 0.004 0.089 
    Time
2
 --- --- --- --- --- --- 
 
Note. A quadratic model (Time
2
) was firstly tested. Where no evidence for a quadratic model 
was identified a linear model (Time) was tested. Models adjust for gender and age. Time is 
treated as a continuous variable.  
*** p 0.001; **p < 0.01; *p < 0.05. 
Highlights 
 The diurnal dynamics of five symptom constructs in Major Depression (MDD) were explored 
 The MDD group had distinct dynamics to controls in affect, self-esteem, suicidality and tiredness 
 Tiredness had decreased variability and all other symptoms increased variability in MDD 
 Increased instability was found in affect, self-esteem and suicidality in MDD 
 Positive affect had a more pronounced and tiredness a less pronounced diurnal time-trend in 
MDD 
 
